Wang et al. pointed out that CXCL5 was a cancer-secreted chemokine that attracted CXCR2-expressing myeloid-derived suppressor cells (MDSCs) and, correspondingly, pharmacological inhibition of CXCR2 impeded tumor progression [47]. The gene discussed is CXCR2; the disease is cancer.